Insulet Corporation (PODD) — Research Summary as of August 3, 2026

Company Overview

Insulet Corporation (NASDAQ: PODD) is a medical device company headquartered in Acton, Massachusetts, founded in 2000. It develops, manufactures, and sells insulin delivery systems — most notably the Omnipod platform — for people with insulin-dependent diabetes [25][22]. As of August 2, 2026, the stock traded at approximately $165.35 with a market capitalization of $11.57 billion and a P/E ratio of 38.49 [14].

---

Key Recent Catalysts (Last ~1–3 Months)